Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 2
2005 2
2006 1
2007 1
2009 1
2010 1
2011 1
2012 2
2016 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial).
Verstappen SM, Jacobs JW, van der Veen MJ, Heurkens AH, Schenk Y, ter Borg EJ, Blaauw AA, Bijlsma JW; Utrecht Rheumatoid Arthritis Cohort study group. Verstappen SM, et al. Ann Rheum Dis. 2007 Nov;66(11):1443-9. doi: 10.1136/ard.2007.071092. Epub 2007 May 22. Ann Rheum Dis. 2007. PMID: 17519278 Free PMC article. Clinical Trial.
Adverse events and factors associated with toxicity in patients with early rheumatoid arthritis treated with methotrexate tight control therapy: the CAMERA study.
Verstappen SM, Bakker MF, Heurkens AH, van der Veen MJ, Kruize AA, Geurts MA, Bijlsma JW, Jacobs JW; Utrecht Rheumatoid Arthritis Cohort Study Group. Verstappen SM, et al. Ann Rheum Dis. 2010 Jun;69(6):1044-8. doi: 10.1136/ard.2008.106617. Epub 2009 Jul 5. Ann Rheum Dis. 2010. PMID: 19581281 Clinical Trial.
Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trial.
Bakker MF, Jacobs JW, Welsing PM, Verstappen SM, Tekstra J, Ton E, Geurts MA, van der Werf JH, van Albada-Kuipers GA, Jahangier-de Veen ZN, van der Veen MJ, Verhoef CM, Lafeber FP, Bijlsma JW; Utrecht Rheumatoid Arthritis Cohort Study Group. Bakker MF, et al. Ann Intern Med. 2012 Mar 6;156(5):329-39. doi: 10.7326/0003-4819-156-5-201203060-00004. Ann Intern Med. 2012. PMID: 22393128 Free article. Clinical Trial.
A good response to early DMARD treatment of patients with rheumatoid arthritis in the first year predicts remission during follow up.
Verstappen SM, van Albada-Kuipers GA, Bijlsma JW, Blaauw AA, Schenk Y, Haanen HC, Jacobs JW; Utrecht Rheumatoid Arthritis Cohort Study Group (SRU). Verstappen SM, et al. Ann Rheum Dis. 2005 Jan;64(1):38-43. doi: 10.1136/ard.2003.014928. Epub 2004 May 6. Ann Rheum Dis. 2005. PMID: 15130899 Free PMC article. Clinical Trial.
Radiographic joint damage in rheumatoid arthritis is associated with differences in cartilage turnover and can be predicted by serum biomarkers: an evaluation from 1 to 4 years after diagnosis.
Verstappen SM, Poole AR, Ionescu M, King LE, Abrahamowicz M, Hofman DM, Bijlsma JW, Lafeber FP; Utrecht Rheumatoid Arthritis Cohort Study group (SRU). Verstappen SM, et al. Arthritis Res Ther. 2006;8(1):R31. doi: 10.1186/ar1882. Epub 2006 Jan 10. Arthritis Res Ther. 2006. PMID: 16507130 Free PMC article.